Jane-Guo Shiah
26Patents
9h-index
20Co-inventors
71Inventor score
Filing activity: Apr 30, 2004 → Sep 17, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8512738B2 | Biodegradable intravitreal tyrosine kinase implants | Human Necessities | 58 | Active |
| US8409607B2 | Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods | Emerging Cross-Sectional Technologies | 53 | Active |
| US8685435B2 | Extended release biodegradable ocular implants | Human Necessities | 43 | Active |
| US7771742B2 | Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods | Emerging Cross-Sectional Technologies | 37 | Active |
| US8318070B2 | Ocular implant made by a double extrusion process | Human Necessities | 36 | Active |
| US8968766B2 | Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods | Emerging Cross-Sectional Technologies | 19 | Active |
| US8034370B2 | Ocular implant made by a double extrusion process | Human Necessities | 19 | Active |
| US8034366B2 | Ocular implant made by a double extrusion process | Human Necessities | 17 | Active |
| US8048445B2 | Ocular implant made by a double extrusion process | Human Necessities | 13 | Active |
| US9192511B2 | Ocular implant made by a double extrusion process | Human Necessities | 5 | Active |
| US8506987B2 | Ocular implant made by a double extrusion process | Human Necessities | 5 | Active |
| US9610246B2 | Sustained drug delivery implant | Human Necessities | 4 | Active |
| US7749530B2 | Kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US9233070B2 | Biodegradable intravitreal tyrosine kinase implants | Human Necessities | 3 | Active |
| US10076526B2 | Ocular implant made by a double extrusion process | Human Necessities | 3 | Active |
| US8974812B2 | Extended release biodegradable ocular implants | Human Necessities | 3 | Active |
| US8455656B2 | Kinase inhibitors | Human Necessities | 2 | Active |
| US8404267B2 | Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods | Emerging Cross-Sectional Technologies | 2 | Active |
| US10076492B2 | Biodegradable intravitreal tyrosine kinase implants | Human Necessities | 2 | Active |
| US8143410B2 | Kinase inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US10702539B2 | Ocular implant made by a double extrusion process | Human Necessities | 1 | Active |
| US8895049B2 | Extended release biodegradable ocular implants | Human Necessities | 1 | Active |
| US10231926B2 | Sustained drug delivery implant | Human Necessities | 1 | Active |
| US10881608B2 | Biodegradable intravitreal tyrosine kinase implants | Human Necessities | 0 | Active |
| US8778381B2 | Ocular implant made by a double extrusion process | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.